Literature DB >> 6261680

Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases.

P C Dowling, S D Cook.   

Abstract

Serological evidence of either acute cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection was sought in a large series of patients with Guillain-Barré syndrome (GBS) and control subjects. Using an indirect immunofluorescent technique, IgM antibody directed against CMV was found in the serum of 33 of 220 GBS patients. The CMV-positive patients were mainly young adults (average age, 25.6 years), previously healthy, and the most common prodromal illness was mild coryza. Alternations in serum CMV IgM antibody level closely paralleled the patients' clinical course. Persistently elevated titers were found in patients with severe and protracted paralysis, whereas rapid disappearance of virus-specific IgM characterized benign cases. Striking time clusters of CMV-seropositive patients were found during three periods between January, 1971, and October, 1973. In a parallel study, EBV-specific IgM was found in 8 of 100 GBS patients (8%). All 8 also had heterophil antibodies. Thus, EBV and CMV appear related to a substantial number of cases of this primary demyelinating disease and, to date, are the two most common agents we have been able to link with GBS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261680     DOI: 10.1002/ana.410090709

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

2.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Peripheral nervous system manifestations of infectious diseases.

Authors:  Kate T Brizzi; Jennifer L Lyons
Journal:  Neurohospitalist       Date:  2014-10

4.  Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome.

Authors:  G Nakos; E Tziakou; L Maneta-Peyret; C Nassis; M E Lekka
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

5.  Guillain-Barré syndrome and Campylobacter jejuni: a serological study.

Authors:  J Kaldor; B R Speed
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

Review 6.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

7.  Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis.

Authors:  E Ece Boylu; R Erdem Toğrol; Mehmet Güney Senol; M Fatih Ozdağ; Mehmet Saraçoğlu
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 8.  Guillain-Barré syndrome after varicella-zoster infection. Report of two cases.

Authors:  E A Sanders; A C Peters; J W Gratana; R A Hughes
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

9.  Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein.

Authors:  M Adelmann; C Linington
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

10.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.